Nexmos
The Innovative DNA Aptamer Bio Technology Pioneer
Aptamin
World’s First Antioxidant DNA Aptamer Meta-Platform
Therapeutics
BBB Shuttle Aptamer & Degenerative Brain Disease Research
Healthcare
Healthy Lives & Brighter Future with Aptamin®
팝업레이어 알림
Aptamin®
Another DNA Aptamer that the intellectual property rights
registered and owned by Nexmos is actively, and stably delivering
antioxidant and maximizing (boost) the efficacies via ROS removal,
and unexpectable synergy effects of DNA itself.
Therapeutics
The new generation of DNA Aptamer technology, defined by
Nexmos, is adaptable for new possibilities of incurable diseases,
as BBB Shuttle Aptamer and degenerative brain diseases’
candidate substances.
Healthcare
Nexmos experts unveiled the confirmed efficacies of Aptamin®, and
those create a new era of commercial DNA for innovative personal
care and dietary supplements.
About us
Flying Towards To The Next Cosmos
A global therapeutics and healthcare market
pioneer based on unrivaled world’s first
commercial DNA Aptamer
Nexmos is an innovative, biotechnology R&D company with a
brand-new DNA meta-platform protected by global intellectual
properties. Founded in 2014, the company has developed
DNA-based Aptamer technology with registered related patents
and worked on the healthcare and therapeutics industry using its
technology.